Freeline Therapeutics to Host Second Quarter 2023 Financial Results Call

Plugin JSON Content Importer Pro not running: Check Licence! Check that a Licence is active for https://freeline.life
You might also like
Freeline to Participate in Upcoming Investor Conferences
Freeline files registration statement for proposed initial public offering in the United States
Freeline to Participate in Evercore ISI 4th Annual HealthCONx Conference
Freeline to Present Data at the 2021 Virtual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) and the 17th Annual WORLDSymposium™ 2021
Freeline Announces 2022 Corporate Priorities and Guidance
Freeline Announces Updated Development Plan and Timelines for FLT190 for People with Fabry Disease
Get in touch

+44 (0)1438 906870
contact@freeline.life

Follow us on our social channels